MADISON, Wis. – U.S. Reps. Mike Gallagher, R-Wis., and Ro Khanna, D-Calif., headlined a two-part webinar series on how research and development investment can build a stronger economy. Entitled Shaping…
National experts in business ethics and technology transfer discuss the opportunities and challenges of moving COVID-19 inventions to market
CONTACT: Jeanan Yasiri Moe, Director of Strategic Communications [email protected] | 608.960.9892 Oct. 21 webinar explores what is happening in response to innovations emerging in the wake of the pandemic MADISON,…
Campus leaders headline Oct. 6 talk on transforming UW-Madison’s innovation ecosystem
CONTACT: Jeanan Yasiri Moe, Director of Strategic Communications [email protected] | 608.960.9892 Chancellor Blank, entrepreneur James Berbee and more explore how the university is rising to meet the moment MADISON, Wis….
Crossroads of Ideas launches fall programming with insights on the election
CONTACT: Jeanan Yasiri Moe, Director of Strategic Communications [email protected] | 608.960.9892 Gear up for the first debate with UW experts at September 24 talk MADISON, Wis. – The first presidential…
WARF Therapeutics 2020 call for fall proposals
CONTACT: Jacqui Fuller, Strategic Communications and Marketing Manager [email protected] | 608.960.9881 Fall WARF Therapeutics (WT) Program Proposal Deadline: October 15 MADISON, Wis. – WARF Therapeutics encourages researchers working on a…
Building Momentum: A message from Greg Keenan
During this time of uncertainty caused by the COVID-19 pandemic, I want to start by wishing you and yours well. It has been gratifying to see how quickly our researchers…
Technology Monitor: Science meets sports, a prototype takes shape, and more
WARF Accelerator speeds the development of technologies with exceptional potential for commercial success. With targeted funding and expert advice from seasoned business mentors known as Catalysts, WARF Accelerator helps inventors…
Accelerator Chronicle: An ultra-rare combination
This year the world’s attention has been seized by crisis. But a gene therapy to restore sight to the most vulnerable is advancing towards clinical trial, championed by a University…